Who was studied, and how
Two numbers in the abstract
Where each one falls
Where it lands on the map
people with type 2 diabetes, in this paper
Already taking metformin therapy, or nottheir own situation, not assigned
on metformin therapy
not on metformin therapy
Metformin therapy went with lower colorectal cancer risk−27%
correlation, not a testAlready taking metformin users, or nottheir own situation, not assigned
on metformin users
not on metformin users and other treatment users
Metformin users went with lower colorectal cancer risk−22%
correlation, not a testthe abstract, start to end
… risk was also observed (unadjusted OR=0.73, 95% CI: 0.62-0.86, p=0.0002).
… and other treatment users (adjusted OR=0.78, 95% CI: 0.70-0.87, p<0.00001).
← favours treatmentfavours comparator →
could be chanceColorectal cancer riskmetformin therapy
OR 0.730.62–0.86
Colorectal cancer riskmetformin users vs non-metformin users and other treatment users
OR 0.780.70–0.87
MetforminAdverse events & safety
1 / 4